Vetnews | November 2026 46 « BACK TO CONTENTS Faecal microbiota transplantation (FMT) is emerging as a powerful tool in veterinary medicine, offering new hope for dogs with a variety of acute and chronic gastrointestinal (GI) disorders. This technique, which involves transferring the intestinal microbiome from a healthy donor to a diseased recipient, aims to restore a balanced gut environment and alleviate disease. While the concept has ancient roots, its application in modern medicine is driven by our growing understanding of the crucial role the microbiome plays in overall health. Efficacy in Acute and Chronic Conditions FMT has demonstrated significant promise in several clinical scenarios. One of the most compelling applications is in puppies suffering from parvovirus enteritis. A randomised controlled trial showed that puppies treated with FMT in addition to standard care had significantly shorter hospitalisation and recovery times (a median of 3 days versus 6 days for the control group). (Jergens AE, Schreiner CA, Frank DE, et al. A Scoring Index for disease activity in canine inflammatory bowel disease. J. Vet. Intern. Med. 2003;17(3):291-297. DOI:10.1111/j.1939-1676.2003.tb02450.x) The benefits extend to dogs with other forms of acute diarrhoea. In one study, a single FMT was as effective as metronidazole in improving faecal scores by day 7. Crucially, at day 28, the FMTtreated dogs had a restored, healthy intestinal microbiome, whereas the metronidazole group exhibited significant dysbiosis. (Chapman BC, Moore HB, Overbey DM, et al. Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review. J. Trauma Acute Care Surg. 2016;81(4):756-764. DOI:10.1097/TA.0000000000001195) For dogs with chronic enteropathies (CE), including refractory cases of inflammatory bowel disease (IBD), FMT is proving to be a valuable adjunctive therapy. In a case series involving nine dogs with IBD unresponsive to conventional treatments like corticosteroids and cyclosporine, FMT led to a significant decrease in clinical disease activity scores. This improvement was linked to an increase in beneficial bacteria such as Fusobacterium, a key producer of short-chain fatty acids essential for gut health. (AlShawaqfeh MK, Wajid B, Minamoto Y, et al. A dysbiosis index to assess microbial changes in fecal samples of dogs with chronic inflammatory enteropathy. FEMS Microbiol. Ecol. 2017;93(11). DOI:10.1093/femsec/fix136) A larger retrospective study of 36 dogs with poorly responsive CE further supports these findings. All dogs in the study had failed to respond adequately to standard therapies. After receiving a series of FMTs, 75% of the dogs showed clinical improvement, manifesting as increased activity levels, better faecal consistency, weight gain, and improved appetite. Notably, some dogs were able to have their maintenance corticosteroid doses reduced. Side effects were uncommon and mild, typically limited to self-resolving diarrhoea or discomfort within 48 hours of the procedure. Paramsothy S, Nielsen S, Kamm MA, et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology 2019;156(5):1440-1454.e2. DOI:10.1053/j.gastro.2018.12.001 The FMT Procedure: From Donor to Recipient While formal, evidence-based guidelines are still under development by the Companion Animal Faecal Bank Consortium, a general protocol has been established through clinical experience. Donor Selection: The success of FMT hinges on the quality of the donor. A suitable donor must be a clinically healthy adult with a normal body condition score and no history of chronic GI disease. They should not have received antibiotics for at least six months and should not be fed a raw food diet. Rigorous screening for intestinal parasites is essential. To ensure a rich and diverse microbiome, potential donors are often screened using a faecal dysbiosis index, which assesses the balance of key bacterial groups. The Process: The transplant material can be fresh or frozen (thawed) faeces. A typical dose is around 5 grams of faeces per kilogram of the recipient’s body weight (for dogs up to 30kg). For dogs over 30kg, 2- 3 g of faeces is used. The faeces are blended with sterile saline (20-120ml), filtered to remove particulate matter, and the filtrate is drawn into syringes, which should be left at room temperature or warmed in a water bath before use. A New Frontier in Gastroenterology: Faecal Microbiota Transplantation This article is an adaptation of the original paper, "Fecal microbiota transplantation for GI disorders" by Linda Toresson, available on the Royal Canin Academy. >>>47
RkJQdWJsaXNoZXIy OTc5MDU=